Repertoire CEO Torben Straight Nissen describes how Repertoire is revolutionizing T-cell based immune medicine with a focus on cancer and autoimmune diseases. Watch the full CEO Chat for more including how Repertoire is partnering with Bristol Myers Squibb to develop tolerizing vaccines for up to three autoimmune diseases. More from Flagship @ JPM2025 here.
Related Companies
- Repertoire® Immune Medicines Founded: 2019
